HEATHER SAUDER: Open Payments
NPI 1336627843 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,849 in 46 payments from 13 companies in 2025. Trend: 2023 $854 · 2024 $2,009 · 2025 $1,849
Food & beverage: $1,849
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $479 |
| Madrigal Pharmaceuticals | 2 | $296 |
| ABBVIE INC. | 10 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $181 |
| GENZYME CORPORATION | 2 | $148 |
| Phathom Pharmaceuticals, Inc. | 1 | $141 |
| Novo Nordisk Inc | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Celltrion USA Inc. | 4 | $75 |
| Intercept Pharmaceuticals, Inc. | 1 | $30 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, VOQUEZNA, RINVOQ, Wegovy, OMVOH, EOHILIA.
Industry payments across PA — which companies pay providers there.
